Oragenics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,032.20
939.90
-
-
-
30.10
Cost of Goods Sold (COGS) incl. D&A
419.80
369.60
71.20
75.00
65.80
30.10
Gross Income
612.40
570.30
71.20
75.00
65.80
30.10
SG&A Expense
16,822.60
6,386.80
11,709.70
8,467.50
6,652.50
9,964
EBIT
16,210.20
5,816.50
-
8,547.30
6,721.40
9,995.30
Unusual Expense
-
-
-
-
188.70
-
Non Operating Income/Expense
135.50
6.00
0.80
14.00
7.30
0.50
Interest Expense
17.50
4.00
76.70
4.10
216.30
5.80
Pretax Income
16,068.80
5,789.50
11,840.10
8,497.30
6,731.50
9,914.10
Consolidated Net Income
16,068.80
5,789.50
11,840.10
8,497.30
6,731.50
9,914.10
Net Income
16,068.80
5,789.50
11,840.10
8,497.30
6,731.50
9,914.10
Net Income After Extraordinaries
16,068.80
5,789.50
11,968.80
9,981.30
6,731.50
9,914.10
Net Income Available to Common
16,068.80
5,789.50
11,711.30
8,467.00
6,731.50
11,326.20
EPS (Basic)
5.60
1.60
3.20
1.60
1.37
0.87
Basic Shares Outstanding
2,877.90
3,615.40
3,665.60
4,460.00
4,926.30
13,039.10
EPS (Diluted)
5.58
1.60
3.19
1.57
1.37
0.87
Diluted Shares Outstanding
2,877.90
3,615.40
3,665.60
4,460.00
4,926.30
13,039.10
EBITDA
16,133.70
5,788.80
11,714.40
8,472.30
6,655.60
9,965.20
Other Operating Expense
-
-
4.70
4.80
3.10
1.20
Non-Operating Interest Income
23.50
37.00
21.40
40.10
10.20
86.50
About Oragenics
View Profile
